Locations:

Abu Dhabi|Canada|Florida|London|Nevada|Ohio|

Search

Tag: atherosclerosis

illustration of coronary artery with calcified plaque

September 26, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

Coronary Artery Calcium Scoring Improves Accuracy of Cardiovascular Risk Screening

Observational study supports adding CAC score to traditional risk factors for precision medicine approach

23-HVI-3606661_atherosclerosis_650x450

March 7, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

Targeting Inflammation Is Best Way to Reduce Residual Risk in Statin-Treated Patients, Study Suggests

Inflammation found more predictive of events than LDL-C in pooled analysis of RCTs

22-HVI-3276958 supplement-pills_650x450

November 7, 2022/Heart, Vascular and Thoracic/Preventive Cardiology

Dietary Supplements Don’t Stack Up to Low-Dose Statin Therapy for LDL-C Reduction

Randomized controlled study undercuts unsubstantiated ‘heart health’ claims

650×450-Abazeed-Main

March 11, 2018/Heart, Vascular and Thoracic/Research

Genetic Analysis of Evacetrapib Outcomes Fails to Confirm Findings with Dalcetrapib

Potential of CETP inhibitors in patients with AA genotype must await outcome trial

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cleveland Clinic’s Stanley Hazen, MD, PhD, Named a 2017 AHA Distinguished Scientist

November 16, 2017/Heart, Vascular and Thoracic/News & Insights

Cleveland Clinic’s Stanley Hazen, MD, PhD, Named a 2017 AHA Distinguished Scientist

Honored for multiple discoveries in atherosclerosis, including role of the gut microbiome

CANTOS: Why It’s a Big Deal — and 5 More Things to Know About It

November 3, 2017/Heart, Vascular and Thoracic/Insight & Perspectives

CANTOS: Why It’s a Big Deal — and 5 More Things to Know About It

‘A gateway to...a new range of therapies for atherosclerosis’

Gut Microbes

December 17, 2015/Heart, Vascular and Thoracic/Research

Nonlethal Targeting of Gut Microbes Successfully Treats Atherosclerosis

Study heralds potential new approach to cardiometabolic diseases

BackPage 1 of 1Next

Advertisement

Ad